Spots Global Cancer Trial Database for A Phase 2 Efficacy Study of CLS003 ICVT in Subjects With Cutaneous Warts.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Phase 2 Efficacy Study of CLS003 ICVT in Subjects With Cutaneous Warts.
Official Title: A Phase 2, Randomized, Vehicle-Controlled, Double-Blind, Study to Evaluate Efficacy and Safety of Topical Ionic Contra-viral Therapy (ICVT) Comprised of CLS003 in Cutaneous Warts
Study ID: NCT02333643
Conditions
Study Description
Brief Summary: A phase 2, randomized, vehicle-controlled, double-blind study to assess the efficacy, safety and pharmacodynamics (PD) of topically applied CLS003 in otherwise healthy patients with cutaneous warts.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
LUMC/Centre for Human Drug Research, Leiden, , Netherlands
Contact Details
Name: J. (Koos) Burggraaf, MD, PhD
Affiliation: Centre for Human Drug Research
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
